These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4139935)

  • 81. Pharmacology of solanine.
    Nishie K; Gumbmann MR; Keyl AC
    Toxicol Appl Pharmacol; 1971 May; 19(1):81-92. PubMed ID: 4105761
    [No Abstract]   [Full Text] [Related]  

  • 82. Ventricular dysrhythmias following an alfentanil anesthetic in a patient on reserpine for hypertension.
    Jahr JS; Weber S
    Acta Anaesthesiol Scand; 1991 Nov; 35(8):788-9. PubMed ID: 1722376
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Respiratory failure and isoprenaline.
    Barer GR; Howard P; Warren P; Astin PW
    Clin Sci; 1970 Dec; 39(6):19P. PubMed ID: 4099707
    [No Abstract]   [Full Text] [Related]  

  • 84. Cocaine-induced ventricular arrhythmias and rapid atrial fibrillation temporally related to naloxone administration.
    Merigian KS
    Am J Emerg Med; 1993 Jan; 11(1):96-7. PubMed ID: 8447884
    [No Abstract]   [Full Text] [Related]  

  • 85. Naloxone-associated morbidity and mortality.
    Pallasch TJ; Gill CJ
    Oral Surg Oral Med Oral Pathol; 1981 Dec; 52(6):602-3. PubMed ID: 7031551
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Morphine "anesthesia"--a perspective.
    Lowenstein E
    Anesthesiology; 1971 Dec; 35(6):563-5. PubMed ID: 5124736
    [No Abstract]   [Full Text] [Related]  

  • 87. Case 3--1992. General anesthesia complicated by unexpected hypertension and tachycardia.
    Reich DL; Bucek JL; Wolf NM; Klumpe DB; Cullen DJ
    J Cardiothorac Vasc Anesth; 1992 Jun; 6(3):360-5. PubMed ID: 1611003
    [No Abstract]   [Full Text] [Related]  

  • 88. Desipramine and premature ventricular contractions.
    Gorman JM
    Am J Psychiatry; 1982 Jan; 139(1):142. PubMed ID: 6172987
    [No Abstract]   [Full Text] [Related]  

  • 89. Naloxone interventions in opioid overdoses: a systematic review protocol.
    Shaw LV; Moe J; Purssell R; Buxton JA; Godwin J; Doyle-Waters MM; Brasher PMA; Hau JP; Curran J; Hohl CM
    Syst Rev; 2019 Jun; 8(1):138. PubMed ID: 31186071
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Naloxone dosage for opioid reversal: current evidence and clinical implications.
    Rzasa Lynn R; Galinkin JL
    Ther Adv Drug Saf; 2018 Jan; 9(1):63-88. PubMed ID: 29318006
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Ventricular Tachycardia After Naloxone Administration: a Drug Related Complication? Case Report and Literature Review.
    Lameijer H; Azizi N; Ligtenberg JJ; Ter Maaten JC
    Drug Saf Case Rep; 2014 Dec; 1(1):2. PubMed ID: 27747471
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Naloxone in opioid poisoning: walking the tightrope.
    Clarke SF; Dargan PI; Jones AL
    Emerg Med J; 2005 Sep; 22(9):612-6. PubMed ID: 16113176
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The cardiovascular effects of naloxone administration after fentanyl anesthesia in hypercapnic patients.
    Kishikawa K; Namiki A; Iwasaki H
    J Anesth; 1989 Mar; 3(1):48-53. PubMed ID: 15236056
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of agitated critically ill patients.
    Wagner BK; O'Hara DA
    Clin Pharmacokinet; 1997 Dec; 33(6):426-53. PubMed ID: 9435992
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Failure to reproduce the in vitro cardiac electrophysiological effects of naloxone in humans.
    Oldroyd KG; Rankin AC; Gray CE; Harvey K; Borland W; Rae AP; Cobbe SM
    Br J Clin Pharmacol; 1994 Mar; 37(3):289-94. PubMed ID: 8198939
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Reversal agents in sedation and anesthesia: a review.
    Anderson JA
    Anesth Prog; 1988; 35(2):43-7. PubMed ID: 3137841
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Use of naloxone in septic shock.
    Canady J; Williams W; Thompson I; Vincent GS; Hoover E
    J Natl Med Assoc; 1989 Jun; 81(6):669-73. PubMed ID: 2746688
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Narcotic reversal in hypercapnic dogs: comparison of naloxone and nalbuphine.
    Mills CA; Flacke JW; Flacke WE; Bloor BC; Liu MD
    Can J Anaesth; 1990 Mar; 37(2):238-44. PubMed ID: 2311152
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Drug-induced cardiovascular diseases.
    Deglin SM; Deglin JM; Chung EK
    Drugs; 1977 Jul; 14(1):29-40. PubMed ID: 18329
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Ventricular irritability associated with the use of naloxone hydrochloride. Two case reports and laboratory assessment of the effect of the drug on cardiac excitability.
    Michaelis LL; Hickey PR; Clark TA; Dixon WM
    Ann Thorac Surg; 1974 Dec; 18(6):608-14. PubMed ID: 4139935
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.